• linkedin
  • Increase Font
  • Sharebar

    AUA '17 puts emphasis squarely on 'value'

    New era of value-based care permeates policy, clinical presentations

     

    Stone Disease

    Brian R. Matlaga, MD, MPHDr. MatlagaThree major themes emerge from the meeting’s sessions on surgical treatment of stone disease: the role of single-use ureteroscopes, hospital readmissions after stone surgery, and stone-free rate—as defined by computed tomography—after ureteroscopy. So says Brian R. Matlaga, MD, MPH, professor of urology at the Johns Hopkins University School of Medicine in Baltimore.

    “Although single-use ureteroscopes have been around for some time, the recent introduction of a digital single-use ureteroscope has generated great interest in defining the role of these devices in clinical practice,” Dr. Matlaga said. “The podium and poster sessions at this year’s meeting will feature studies that will provide a better understanding of how these devices may fit into a urology practice.

    “There are multiple studies which will nicely detail the clinical efficacy of these devices, characterizing how they may function in the surgical environment, he said, adding that other studies will provide an important understanding of how the cost of a single-use endoscope will affect the economics of a ureteroscopic procedure.

    “The present health care environment is placing an increasing emphasis on the postoperative experience, particularly with regard to emergency department utilization and hospital readmission, following ureteroscopy,” Dr. Matlaga pointed out. “The annual meeting program has several studies which utilize large-scale datasets to provide better context for this increasingly important metric.”

    In addition, studies will discuss stone-free rate, one of the primary criteria for treatment success with ureteroscopy.

    “The published literature has great heterogeneity in the way in which stone-free is defined,” Dr. Matlaga said. “At the annual meeting, two centers will report on their stone-free outcome following ureteroscopic stone treatment. The unique nature of these studies is twofold: meticulous attention was paid to complete stone fragment extraction, and the stone-free outcome was rigorously defined with CT imaging.”

    Specifically, these are the stone disease abstracts to take note of at this year's meeting, according to Dr. Matlaga:

    MP50-07: Comparison of parameters of standard reusable flexible uretero-renoscopes with a single use uretero-renoscope (Lithovue)

    Grzegorz Fojecki

     

    MP50-08: Limitations of the Lithovue single use digital flexible ureteroscope

    Saum Ghodoussipour

     

    MP50-16: Initial clinical experience with a single-use digital flexible ureteroscope

    Thomas Chi

     

    PD35-10: A prospective case cohort study demonstrates that Lithovue, a single-use flexible disposable ureteroscope, reduces operative time

    Manint Usawachintachit

     

    PD35-11: New digital single-use flexible ureteroscope (Pusen): first clinical experience

    José A. Salvadó

     

    MP75-02: Predictors of ED visits following ureteroscopy

    Graham Machen

     

    MP75-03: Unplanned 30-day encounters after uretero-renoscopy for urolithiasis

    Kefu Du

     

    MP75-12: Prospective evaluation of stone free rates by computed tomography after aggressive ureteroscopy

    Noah Canvasser

     

    PD21-09: True stone free rates of flexible ureteroscopy for renal calculi utilizing strict CT criteria

    Nadya E. York

    Richard R. Kerr
    Kerr is group content director for Urology Times.

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results